Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-07-28Clinical Trial Update: Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis [Phase 3]
A Phase 3 trial comparing two doses of Asacol for moderately active ulcerative colitis assessed safety and efficacy; the study is completed …
-
CLINICAL_TRIALS trial_result · 2011-07-19Clinical Trial Update: Agaricus Blazei Murill (ABM) in Patients With Inflammatory Bowel Disease (IBD) [Phase 2]
A Phase 2 clinical trial evaluating Agaricus blazei Murill (ABM) in inflammatory bowel disease has completed; no efficacy or safety results …
-
FDA approval · 2011-07-14FDA Approved: LIALDA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for LIALDA (mesalamine) from Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: Synbiotic Treatment of Ulcerative Colitis Patients [NA]
The clinical trial investigating a synbiotic treatment for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial evaluating Natura-Alpha for efficacy and tolerability in active ulcerative colitis. The current status of the trial…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-06-23FDA Approved: BUDESONIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for budesonide from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Microparticles in Pediatric Inflammatory Disease
A clinical trial sponsored by Indiana University evaluating microparticles in pediatric inflammatory disease (Crohn's disease and ulcerative…
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I) [Phase 3]
Phase 3 ASCEND I trial comparing high-dose (4.8 g/day) versus standard-dose (2.4 g/day) mesalamine (Asacol) in ulcerative colitis; results h…
-
CLINICAL_TRIALS trial_result · 2011-06-14Clinical Trial Update: Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the safety, tolerability, and pharmacokinetics of HE3286 in adults with active mild-to-moder…
-
CLINICAL_TRIALS research · 2011-06-14Clinical Trial Update: Probiotics in GastroIntestinal Disorders [Phase 2, Phase 3]
Clinical trial update describing Phase 2 and Phase 3 studies evaluating probiotics for ulcerative colitis and Crohn's disease.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis [Phase 1, Phase 2]
The document reports on the safety and preliminary activity of the investigational drug ORE1001 in a Phase 1/2 study for mild to moderate ul…
-
CLINICAL_TRIALS trial_result · 2011-06-01Clinical Trial Update: User Surveillance in Ulcerative Colitis
A completed clinical trial update on user surveillance in Ulcerative Colitis sponsored by Ferring Pharmaceuticals.
-
FDA approval · 2011-05-27FDA Approved: MERCAPTOPURINE — Supplemental Application (Florida Pharmaceutical Products, LLC)
The FDA has approved a supplemental application for mercaptopurine from Florida Pharmaceutical Products, LLC.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission [Phase 3]
Phase 3 trial evaluating Pentasa (mesalamine) once daily for maintenance of remission in Ulcerative Colitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis [Phase 3]
Infliximab (Remicade) was studied in a Phase 3 trial for active ulcerative colitis, focusing on safety and efficacy. The study status is rep…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis [Phase 3]
Phase 3 safety and efficacy evaluation of infliximab (Remicade) in patients with ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: A Comparison of Once a Day Dose Compared to 2 Doses/Day [Phase 3]
Phase 3 trial comparing once-daily dosing to twice-daily dosing of mesalamine for ulcerative colitis; results completed and posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-04-07Clinical Trial Update: A Study of Pentasa in Patients With Ulcerative Colitis
A clinical trial evaluating Pentasa (mesalamine) for Ulcerative Colitis has completed. The study was sponsored by Ferring Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2011-03-31Clinical Trial Update: Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis [Phase 3]
A Phase 3 trial update reports efficacy and safety findings for adalimumab in adults with moderately to severely active ulcerative colitis; …
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis [Phase 1]
A Phase 1 trial comparing ALTH12 to mesalamine enema in left-sided ulcerative colitis has completed, assessing safety and tolerability.
-
FDA approval · 2011-03-23FDA Approved: AZATHIOPRINE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for azathioprine from Rising Pharma Holdings, Inc., under an existing ANDA. This action confirms the…
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: Nutritional State and Intake Nutrients Assessment in Ulcerative Colitis
A completed clinical trial evaluated nutritional status and intake of nutrients in individuals with Ulcerative Colitis. The study is listed …
-
FDA approval · 2011-02-17FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for infliximab from Janssen Biotech, Inc., signaling a labeling update or expansion of its appro…
-
CLINICAL_TRIALS research · 2011-01-26Clinical Trial Update: Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative Colitis
This clinical trial update notes the study's completion. The study investigates hydrogen sulfide detoxification and butyrate metabolism in u…
-
FDA approval · 2011-01-20FDA Approved: SULFASALAZINE — Supplemental Application (Sunrise Pharmaceutical, Inc.)
FDA approved a supplemental application submitted by Sunrise Pharmaceutical, Inc. under ANDA040349 to market a generic form of sulfasalazine…